Sign in
4

Changes in Ownership

RIGEL PHARMACEUTICALS INC Filed Acc 0001140361-23-003441

EVP & Chief Financial Officer acquired 63,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Schorno Dean L · EVP & Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2023-01-26 Grant or award : show line 1 in the form +63,000 201,908 D

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2023-01-26 Grant or award : show line 2 in the form Employee Stock Option (right to buy) +50,000 $2.42 2032-01-24 50,000 100,000 D
2023-01-26 Grant or award : show line 3 in the form Employee Stock Option (right to buy) +125,000 $1.87 2033-01-26 125,000 125,000 D
Loading xslF345X03/form4.xml…